Evaluation of a New Topical Treatment for the Control of Cutaneous Leishmaniasis
<i>Leishmania major</i> (<i>L. major</i>) causes cutaneous leishmaniasis in the Old World. The infection mostly induces a localized lesion restricted to the sand fly bite. The costs and the side effects of current treatments render imperative the development of new therapies...
Main Authors: | Berenice Martínez-Salazar, Vanessa Carregaro Pereira, Yazmin Hauyon-La-Torre, Ali Khamesipour, Fabienne Tacchini-Cottier |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Microorganisms |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2607/8/11/1803 |
Similar Items
-
Gender and Cutaneous Leishmaniasis in Israel
by: Michal Solomon, et al.
Published: (2022-08-01) -
Activity of Amphotericin B-Loaded Chitosan Nanoparticles against Experimental Cutaneous Leishmaniasis
by: Alaa Riezk, et al.
Published: (2020-09-01) -
Cutaneous Leishmaniasis in Algeria; Highlight on the Focus of M’Sila
by: Razika Benikhlef, et al.
Published: (2021-04-01) -
Indirect Fluorescent antibody test for serodiagnosis of visceral leishmaniasis: An epidemiological study in Iraq.
by: Souhaila Ali, et al.
Published: (2012-06-01) -
The therapeutic effect of larval saliva and hemolymph of Lucilia sericata on the treatment of Leishmania major lesion in BALB/c mice946
by: Sara Rahimi, et al.
Published: (2023-02-01)